Giving AI penalties to get better diagnoses
Anyone waiting for the results of a medical test knows the anxious question: "Will my life change completely when I know?" And the relief if you test negative.
Nov 1, 2021
0
30
Anyone waiting for the results of a medical test knows the anxious question: "Will my life change completely when I know?" And the relief if you test negative.
Nov 1, 2021
0
30
Monoclonal antibody therapy is an infusion treatment that can reduce the severity of COVID-19. Here are some of the commonly asked questions about the treatment.
Oct 19, 2021
0
68
Black women physicians in the United States face hurdles and inequities that contribute toward their underrepresentation in medicine, argues an essay in The Lancet by Massachusetts General Hospital (MGH) physician Fatima ...
Oct 15, 2021
4
2
In the four months following the COVID-19 pandemic's arrival in the U.S., the number of patients initiating treatment for kidney failure declined by 30%, a new study in JAMA Network Open found. Notably, Black patients and ...
Oct 14, 2021
0
5
Peritoneal dialysis, like classical haemodialysis, is a form of renal replacement therapy that can often only be used for a limited time as a result of the failure of the peritoneum. Researchers of MedUni Wien were now able ...
Oct 4, 2021
0
58
Men are more at risk of experiencing a severe complication from the COVID-19 virus than women even after vaccination, although the risk is low with only 0.07 percent of partially vaccinated and 0.006 percent of fully vaccinated ...
Oct 4, 2021
0
13
A review article published in the journal Frontiers in Physiology by researchers affiliated with the Federal University of São Paulo (UNIFESP) in Brazil discusses the mechanisms whereby SARS-CoV-2 damages the kidneys, ...
Sep 29, 2021
0
5
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, explored whether COVID-19 is more deadly for some people with diabetes than for others.
Sep 29, 2021
0
2
Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy ...
Sep 17, 2021
0
33
Finerenone reduces the risk of cardiovascular and renal outcomes compared to placebo in patients with type 2 diabetes and all stages of kidney disease. That's the finding of late breaking research presented in a Hot Line ...
Aug 30, 2021
0
33